Next Generation News and Research

RSS

Next Generation Identification System to process fingerprint transactions more effectively

New technology designed to revolutionize law enforcement's ability to process fingerprints has reached its initial operating capability, the FBI announced today.

9 Mar 2011

CCCB selects CLC bio's enterprise platform for next generation sequence analysis

After a thorough head-to-head evaluation against various competing solutions, the Center for Cancer Computational Biology at the Dana-Farber Cancer Institute has selected CLC bio's enterprise platform for next generation sequence analysis.

8 Mar 2011

Scientists sequence Clostridium botulinum genome that produces neurotoxin

Scientists on the Norwich Research Park have sequenced the genome of a novel strain of Clostridium botulinum, one of the most dangerous pathogens known to man. The strain produces an unusual botulinum neurotoxin, known as type A5 neurotoxin, which was isolated by the Health Protection Agency, following a case of wound botulism.

8 Mar 2011

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, announced today the successful completion of its initial in vitro permeation study for its transdermal pain patch project.

8 Mar 2011

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

RainDance Technologies, Inc. and Ambry Genetics, today announced a new collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion genetic screening panel for use on next-generation sequencing systems.

8 Mar 2011

Leading advocacy organizations to mark International Women's Day with panel discussion

Leading advocacy organizations American Jewish World Service, Women Thrive Worldwide and the Modernizing Foreign Assistance Network will mark International Women's Day, on March 8 at 8:30 a.m. with a breakfast and panel discussion highlighting the importance of women to a more effective, accountable, and results-oriented U.S. approach to promoting development in poor countries.

5 Mar 2011

Michael Smith, Merck Canada sponsors CDRD's new post-doctoral fellowship program

The Centre for Drug Research and Development today announced that they have created a new Post-Doctoral Fellowship position with joint sponsorship from the Michael Smith Foundation for Health Research and Merck Canada.

5 Mar 2011

Ziehm Imaging launches next generation hybrid Vision RFD mobile C-arm

Ziehm Imaging has launched a new generation of the Ziehm Vision RFD mobile C-arm. Offering outstanding imaging and a liquid cooling system which allows it to be used over an almost unlimited period of time, the new version is an attractive choice for hybrid ORs.

3 Mar 2011

VICC introduces nation's first personalized cancer decision support tool

Vanderbilt-Ingram Cancer Center has launched the nation's first personalized cancer decision support tool, "My Cancer Genome," to help physicians and researchers track the latest developments in personalized cancer medicine and connect with clinical research trials for their patients.

3 Mar 2011

Groundbreaking discovery in lymphoma research

BC Cancer Agency scientists have discovered that a single gene, CIITA, is implicated in almost 40 per cent of primary mediastinal B-cell lymphomas and 15 per cent of all Hodgkin lymphoma cases.

3 Mar 2011

ASU receives W. M. Keck $1 million grant to build next-generation 3D imaging microscope

The W. M. Keck Foundation has awarded Arizona State University a $1 million grant to the team of scientists led by Deirdre Meldrum, Ph.D., at the Biodesign Institute.

2 Mar 2011

IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India

The Translational Health Sciences and Technology Institute, an autonomous institute of the Indian government's Department of Biotechnology, and the International AIDS Vaccine Initiative announced today an agreement to jointly establish, operate and fund an HIV Vaccine Design Program in India.

2 Mar 2011

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

VaxInnate Corporation today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, worth up to $196 million to fund the development of recombinant seasonal and pandemic flu vaccines.

1 Mar 2011

HHS awards two contracts to accelerate flu vaccine availability

U.S. Department of Health and Human Services awarded two contracts today to help make vaccine available more quickly for seasonal flu outbreaks and pandemics. The contracts for advanced development of new types of vaccine and new ways to make flu vaccine known as next-generation recombinant influenza vaccine total $215 million.

28 Feb 2011

Agilent Technologies acquires Lab901

Agilent Technologies Inc. today announced it has acquired Lab901, a leading electrophoresis equipment and consumables company based in Edinburgh, U.K. The company's automated electrophoresis products are used for DNA, RNA and protein analysis. Financial details of the acquisition were not disclosed.

28 Feb 2011

OrbusNeich's Sapphire II coronary dilatation catheter is now available in the market

OrbusNeich today announced that the next-generation Sapphire II coronary dilatation catheter is now commercially available, following CE Mark approval.

28 Feb 2011

ACT Biotech files SPA with FDA for telatinib combination Phase 3 trial for stomach cancer

ACT Biotech, Inc., a biopharmaceutical company focused on the development of highly targeted, oral therapeutics for the treatment of cancer, announced today that it has filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase 3 trial of telatinib in combination with chemotherapy for the first-line treatment of patients with advanced stomach cancer.

28 Feb 2011

LodgeNet Interactive annual 2010 revenue decreases to $452.2 million

LodgeNet Interactive Corporation today reported annual 2010 revenue of $452.2 million compared to $484.5 million in 2009. Net loss attributable to common stockholders was $(17.4) million or $(0.71) per share (basic and diluted) for 2010 compared to $(13.3) million or $(0.59) per share (basic and diluted) for 2009.

25 Feb 2011

Eigen ei-Nav|Artemis system for prostate biopsy installed at Smilow Comprehensive Prostate Cancer Center

As a world leader in the advancement of the detection and treatment of prostate cancer, the Smilow Comprehensive Prostate Cancer Center at NYU Langone Medical Center is the first medical facility in the Northeast to install ei-Nav|Artemis™, an innovative image guidance and navigation system for prostate biopsy that is manufactured by Eigen.

25 Feb 2011

Warner Chilcott fourth quarter revenue increases 1% to $694.4 million

Warner Chilcott plc today announced its results for the quarter and year ended December 31, 2010. As discussed more fully below, our financial position and results of operations in the quarter ended December 31, 2010 as compared to the prior year quarter were significantly impacted by several important transactions in 2009 and 2010.

25 Feb 2011

Next Generation News and Research

Next Generation Identification System to process fingerprint transactions more effectively

CCCB selects CLC bio's enterprise platform for next generation sequence analysis

Scientists sequence Clostridium botulinum genome that produces neurotoxin

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

Leading advocacy organizations to mark International Women's Day with panel discussion

Michael Smith, Merck Canada sponsors CDRD's new post-doctoral fellowship program

Ziehm Imaging launches next generation hybrid Vision RFD mobile C-arm

VICC introduces nation's first personalized cancer decision support tool

Groundbreaking discovery in lymphoma research

ASU receives W. M. Keck $1 million grant to build next-generation 3D imaging microscope

IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

HHS awards two contracts to accelerate flu vaccine availability

Agilent Technologies acquires Lab901

OrbusNeich's Sapphire II coronary dilatation catheter is now available in the market

ACT Biotech files SPA with FDA for telatinib combination Phase 3 trial for stomach cancer

LodgeNet Interactive annual 2010 revenue decreases to $452.2 million

Eigen ei-Nav|Artemis system for prostate biopsy installed at Smilow Comprehensive Prostate Cancer Center

Warner Chilcott fourth quarter revenue increases 1% to $694.4 million

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News